Appreciate the client service support: on going clear communication, in timely manner, very pleasant demeanor. Also truly appreciate the attention to detail and accuracy in the report. This is a strong advantage over other suppliers.
We are a full service provider of healthcare and pharmaceutical market research solutions backed by our Leave No Stone Unturned Guarantee.
Recognized in the health and pharmaceutical market research industry for our visually intuitive and engaging story-based reports, we move the boardroom conversation from understanding to taking action.
Fueled by our proprietary market research panel of healthcare professionals, our in-house field team consistently delivers more target respondents and larger sample sizes.
Since 2003, we have conducted market research in a variety of health-related areas amassing deep expertise and proprietary norms within the pharmaceutical and healthcare industry.
Appreciate the client service support: on going clear communication, in timely manner, very pleasant demeanor. Also truly appreciate the attention to detail and accuracy in the report. This is a strong advantage over other suppliers.
Great work. The bar is pretty high now.
This project was one of my most complicated to date. Great job from the team.
Excellent experience working with the MD Analytics team on this project. They went out of their way to move quickly to meet our deadlines and went above and beyond to support us with the results. Would love to partner again in the future.
See which formats, survey lengths and topics nine specialties are most open to, based on our study of 289 U.S. and Canadian physicians.
Welcoming all healthcare professionals to join our panel.
AI is showing up in clinical practice, from medical searches to note-taking and chatbots. We asked 300 physicians in the U.S. and Canada what they’re using now, and what they expect to use next.
...
Chart audits offer a closer look at real-world treatment decisions, but they ask more of physicians than a standard survey. We surveyed 150 U.S. and 139 Canadian physicians about what holds them back, how long they are willing to spend on each chart and the incentive structure they prefer.
...
Physicians say they value market research. They also turn down about half the studies they are invited to each month. We asked 139 Canadian and 150 U.S. physicians what makes them accept one invitation and pass on another.
...
Ready to explore how data-driven insights can accelerate your pharmaceutical research? Connect with our team to discuss your goals.